Bayer's Flanax Claim 'Distorts' Lanham Act, 4th Circ. Told

Law360, New York (July 15, 2015, 4:22 PM EDT) -- The small drugmaker at the center of Bayer AG's closely watched trademark case over the foreign brand name for Aleve accused the pharmaceutical giant on Tuesday of trying to "distort the Lanham Act" by claiming rights in a name it's never used domestically.

The filing came in a Fourth Circuit case over a tricky question: whether a global company like Bayer can claim priority trademark rights to a name like "Flanax" — its decades-old Mexican brand name for Aleve — that it exclusively uses overseas.

Bayer claims Belmora LLC is using the name to trick Mexican-American consumers who are familiar with...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!